Sort by
Refine Your Search
-
Country
-
Employer
-
research community in exploring near-analog biologic brain inspired solutions to reduce power consumption in neural networks. In this project you will be involved in a collaborative effort investigating
-
Blindern, Oslo. Job description As a response to the power hungriness of artificial intelligence (AI) there is a growing interest from the research community in exploring near-analog biologic brain inspired
-
, long-acting synthetic GLP-2 analog being developed for short bowel syndrome patients who are dependent on parenteral support. In addition, Ironwood has been a pioneer in the development of LINZESS
-
gastrointestinal (GI) and rare diseases. Ironwood is advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for short bowel syndrome patients who are dependent on parenteral
-
gastrointestinal (GI) and rare diseases. Ironwood is advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for short bowel syndrome patients who are dependent on parenteral